Page last updated: 2024-08-22

vidarabine and Pulmonary Disease, Chronic Obstructive

vidarabine has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Farrow, S; Lea, S; Metryka, A; Plumb, J; Singh, D; Southworth, T	1

Other Studies

1 other study(ies) available for vidarabine and Pulmonary Disease, Chronic Obstructive

Article	Year
IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation. British journal of pharmacology, 2012, Volume: 166, Issue:7 Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Cytokines; Dexamethasone; Drug Resistance; Female; Humans; Interferon-gamma; Janus Kinases; Lipopolysaccharides; Macrophages, Alveolar; Male; Middle Aged; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; RNA, Messenger; Signal Transduction; STAT1 Transcription Factor; Toll-Like Receptor 2; Toll-Like Receptor 4; Vidarabine	2012

Article

Year

IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.

British journal of pharmacology, 2012, Volume: 166, Issue:7

Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Cytokines; Dexamethasone; Drug Resistance; Female; Humans; Interferon-gamma; Janus Kinases; Lipopolysaccharides; Macrophages, Alveolar; Male; Middle Aged; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; RNA, Messenger; Signal Transduction; STAT1 Transcription Factor; Toll-Like Receptor 2; Toll-Like Receptor 4; Vidarabine

2012